Michael A Morse Selected Research

Michael A Morse Research Topics

Disease

155	Neoplasms (Cancer) 12/2024 - 01/2002
38	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 12/2005
20	Breast Neoplasms (Breast Cancer) 12/2024 - 02/2003
14	Colonic Neoplasms (Colon Cancer) 01/2021 - 06/2003
13	Adenocarcinoma 02/2024 - 01/2002
11	Pancreatic Neoplasms (Pancreatic Cancer) 02/2024 - 01/2002
11	Neoplasm Metastasis (Metastasis) 02/2016 - 06/2003
10	Melanoma (Melanoma, Malignant) 12/2016 - 12/2005
7	Microsatellite Instability 01/2020 - 01/2016
6	Diarrhea 01/2020 - 04/2006
5	Inflammatory Breast Neoplasms 02/2024 - 01/2008
5	Carcinoma (Carcinomatosis) 12/2023 - 07/2005
5	Neuroendocrine Tumors (Neuroendocrine Tumor) 12/2022 - 01/2015
5	Fatigue 09/2021 - 04/2006
5	Rectal Neoplasms (Rectal Cancer) 12/2007 - 03/2004
4	Hypoxia (Hypoxemia) 01/2020 - 04/2007
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2019 - 02/2005
4	Disease Progression 01/2019 - 07/2016
4	Ovarian Neoplasms (Ovarian Cancer) 08/2015 - 10/2009
4	Hepatocellular Carcinoma (Hepatoma) 09/2012 - 01/2002
4	Hypersensitivity (Allergy) 06/2011 - 05/2005
3	Cholangiocarcinoma 02/2024 - 01/2009
3	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 08/2007
3	Brain Neoplasms (Brain Tumor) 10/2021 - 08/2003
3	Nausea 01/2020 - 04/2006
3	Carcinoid Tumor (Carcinoid) 01/2020 - 01/2015
3	Vomiting 01/2020 - 12/2009
3	Renal Cell Carcinoma (Grawitz Tumor) 01/2017 - 02/2016
3	Lung Neoplasms (Lung Cancer) 01/2013 - 09/2006
3	Exanthema (Rash) 07/2012 - 04/2006
3	Wilms Tumor (Wilm's Tumor) 06/2010 - 02/2007
3	Fowlpox 08/2008 - 04/2005
2	Inflammation (Inflammations) 02/2024 - 01/2017
2	Biliary Tract Neoplasms (Biliary Tract Cancer) 08/2023 - 08/2023
2	Anemia 01/2023 - 01/2020
2	Cardiomyopathies (Cardiomyopathy) 01/2023 - 09/2007
2	Hyperglycemia 01/2021 - 01/2015

Drug/Important Bio-Agent (IBA)

34	AntigensIBA 01/2023 - 07/2002
32	VaccinesIBA 12/2024 - 08/2005
16	Proteins (Proteins, Gene)FDA Link 12/2023 - 02/2003
16	Neoplasm Antigens (Tumor Antigens)IBA 01/2023 - 01/2002
16	Immune Checkpoint InhibitorsIBA 01/2023 - 06/2015
16	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2023 - 05/2005
16	Capecitabine (Xeloda)FDA Link 01/2021 - 05/2005
16	Bevacizumab (Avastin)FDA Link 08/2014 - 05/2005
15	Carcinoembryonic AntigenIBA 12/2023 - 01/2002
15	Cancer VaccinesIBA 01/2021 - 02/2005
11	Biomarkers (Surrogate Marker)IBA 01/2022 - 03/2005
11	Monoclonal AntibodiesIBA 01/2020 - 08/2007
9	AntibodiesIBA 01/2022 - 06/2010
9	CytokinesIBA 10/2021 - 09/2007
9	Peptides (Polypeptides)IBA 03/2019 - 02/2003
8	IpilimumabIBA 02/2024 - 12/2005
8	Fluorouracil (Carac)FDA LinkGeneric 01/2023 - 03/2004
8	Messenger RNA (mRNA)IBA 06/2021 - 01/2002
8	Interleukin-2 (IL2)IBA 11/2019 - 07/2009
7	NivolumabIBA 02/2024 - 07/2016
6	Irinotecan (Camptosar)FDA LinkGeneric 01/2023 - 01/2008
6	Everolimus FDA Link 01/2018 - 01/2011
6	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2014 - 04/2007
6	Cetuximab (Erbitux)FDA Link 06/2011 - 04/2006
5	Trastuzumab (Herceptin)FDA Link 01/2021 - 09/2007
5	ErbB Receptors (EGF Receptor)IBA 01/2021 - 03/2005
5	Panitumumab (Vectibix)FDA Link 01/2021 - 01/2011
5	AutoantigensIBA 05/2015 - 08/2007
4	X-Linked Inhibitor of Apoptosis ProteinIBA 02/2024 - 01/2008
4	Gemcitabine FDA Link 01/2023 - 12/2009
4	ensituximabIBA 01/2023 - 06/2013
4	RNA (Ribonucleic Acid)IBA 01/2022 - 08/2019
4	T-Cell Antigen Receptors (T-Cell Receptor)IBA 11/2019 - 12/2016
4	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 09/2019 - 09/2002
4	Tyrosine Kinase InhibitorsIBA 02/2015 - 06/2010
3	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2022 - 01/2020
3	Lapatinib (GW572016)FDA Link 01/2021 - 06/2010
3	lonafarnib (SCH 66336)IBA 07/2012 - 02/2011
3	EpitopesIBA 05/2011 - 04/2009
2	birinapantIBA 02/2024 - 01/2013
2	Leucovorin (Folinic Acid)FDA Link 01/2023 - 08/2005
2	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 12/2022 - 01/2015
2	Calcibiotic Root Canal SealerIBA 01/2022 - 01/2016
2	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2022 - 01/2020
2	Photosensitizing Agents (Photosensitizers)IBA 01/2022 - 01/2020
2	B7-H1 AntigenIBA 01/2022 - 10/2019
2	Interleukin-6 (Interleukin 6)IBA 10/2021 - 07/2011
2	cabozantinibIBA 01/2021 - 01/2018
2	telotristat ethylIBA 01/2020 - 01/2020
2	3-Iodobenzylguanidine (Iobenguane)IBA 01/2020 - 11/2018
2	Protein Isoforms (Isoforms)IBA 01/2020 - 08/2014
2	BilirubinIBA 01/2020 - 05/2011
2	pembrolizumabIBA 11/2019 - 05/2018
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 09/2019 - 08/2015

Therapy/Procedure

67	Therapeutics 12/2024 - 01/2002
48	Immunotherapy 01/2022 - 01/2002
40	Drug Therapy (Chemotherapy) 12/2022 - 07/2005
14	Radiotherapy 12/2022 - 03/2004
8	Chemoradiotherapy 11/2011 - 01/2002
5	Adjuvant Chemotherapy 08/2023 - 11/2006
3	Hepatectomy 07/2009 - 03/2007
2	Photochemotherapy (Photodynamic Therapy) 01/2022 - 01/2020
2	Blood Component Removal (Apheresis) 12/2019 - 05/2019